Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 54, Issue 8, 2006, Pages 2505-2514

  Lapteva, Larissa ^a,e   Nowak, Miroslawa ^a   Yarboro, Cheryl H ^a   Takada, Kazuki ^a   Roebuck Spencer, Tresa ^b   Weickert, Thomas ^a   Bleiberg, Joseph ^b   Rosenstein, Donald ^a   Pao, Maryland ^a   Patronas, Nicholas ^a   Steele, Sonya ^a   Manzano, Melissa ^a   Van Der Veen, Jan Willem C ^a   Lipsky, Peter E ^a   Marenco, Stefano ^a   Wesley, Robert ^a   Volpe, Bruce ^c   Diamond, Betty ^d   Illei, Gabor G ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL REHABILITATION HOSPITAL   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d Columbia University College of Physicians and Surgeons ^*  (United States)

^e NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CHOLINE; CREATINE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; PENTAPEPTIDE; PREDNISONE; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; ATTENTION; BECK DEPRESSION INVENTORY; COGNITION; COGNITIVE DEFECT; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DEPRESSION; DEPTH PERCEPTION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEMORY; MOTOR ACTIVITY; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOMOTOR ACTIVITY; SYSTEMIC LUPUS ERYTHEMATOSUS; WHITE MATTER; WIDE RANGE ACHIEVEMENT TEST 3;

ADULT; AGED; AUTOANTIBODIES; BRAIN; COGNITION DISORDERS; DEPRESSION; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 33747001788     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22031     Document Type: Article

References (56)

1. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
2. Utset TO, Golden M, Siberry G, Kiri N, Crum RM, Petri M. Depressive symptoms in patients with systemic lupus erythematosus: association with central nervous system lupus and Sjogren's syndrome. J Rheumatol 1994;21:2039-45.
3. Carbotte RM, Denburg SD, Denburg JA. Prevalence of cognitive impairment in systemic lupus erythematosus. J Nerv Ment Dis 1986;174:357-64.
4. Hay EM, Black D, Huddy A, Creed F, Tomenson B, Bernstein RM, et al. Psychiatric disorder and cognitive impairment in systemic lupus erythematosus. Arthritis Rheum 1992;35:411-6.
5. Kozora E, Thompson LL, West SG, Kotzin BL. Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 1996;39:2035-45.
6. Brey RL, Holliday SL, Saklad AR, Navarrete MG, Hermosillo-Romo D, Stallworth CL, et al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 2002;58:1214-20.
7. Denburg SD, Carbotte RM, Ginsberg JS, Denburg JA. The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus. J Int Neuropsychol Soc 1997:3:377-86.
8. Hanly JG, Hong C, Smith S, Fisk JD. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum 1999;42:728-34.
9. Denburg JA, Carbotte RM, Denburg SD. Neuronal antibodies and cognitive function in systemic lupus erythematosus. Neurology 1987;37:464-7.
10. Ginsburg KS, Wright EA, Larson MG, Fossel AH, Albert M, Schur PH, et al. A controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus. Arthritis Rheum 1992;35:776-82.
11. Carlomagno S, Migliaresi S, Ambrosone L, Sannino M, Sanges G, Di Iorio G. Cognitive impairment in systemic lupus erythematosus: a follow-up study. J Neurol 2000;247:273-9.
12. Mikdashi J, Handwerger B. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland Lupus Cohort. Rheumatology (Oxford) 2004;43:1555-60.
13. Glanz BI, Slonim D, Urowitz MB, Gladman DD, Gough J, MacKinnon A. Pattern of neuropsychologic dysfunction in inactive systemic lupus erythematosus. Neuropsychiatry Neuropsychol Behav Neurol 1997;10:232-8.
14. Monastero R, Bettini P, Del Zotto E, Cottini E, Tincani A, Balestrieri G, et al. Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations. J Neurol Sci 2001;184:33-9.
15. Wilkinson G. Wide Range Achievement Test (WRAT-3). Wilmington (DE): The Psychological Corporation; 1993.
16. Nelson M. The use of current reading ability in the assessment of dementia. Br J Soc Clin Psychol 1975;14:259-67.
17. Johnstone B, Wilhelm K. The longitudinal study of the WRAT-R Reading subtest: is it an appropriate estimate of premorbid intelligence? J Int Neuropsychol Soc 1996;2:282-5.
18. Ross AJ, Sachdev PS. Magnetic resonance spectroscopy in cognitive research. Brain Res Brain Res Rev 2004;44:83-102.
19. Brenner RE. The proton NMR spectrum in acute EAE: the significance of change in the Cho/Cr ratio. Magn Reson Med 1993;29:737-45.
20. Arnold DL, de Stefano N, Narayanan S, Matthews PM. Proton MR spectroscopy in multiple sclerosis. Neuroimaging Clin N Am 2000;10:789-98.
21. Friedman SD, Stidley CA, Brooks WM, Hart BL, Sibbitt WL Jr. Brain injury and neurometabolic abnormalities in systemic lupus erythematosus. Radiology 1998;209:79-84.
22. Lim MK, Suh CH, Kim HJ, Cho YK, Choi SH, Kang JH. Systemic lupus erythematosus: brain MR imaging and single voxel hydrogen IMR spectroscopy. Radiology 2000;217:43-9.
23. Brooks WM, Jung RE, Ford CC, Greinel EJ, Sibbitt WL Jr. Relationship between neurometabolite derangement and neurocognitive dysfunction in systemic lupus erythematosus. J Rheumatol 1999;26:81-5.
24. Sabet A, Sibbitt WL Jr, Stidley CA, Danska J, Brooks WM. Neurometabolite markers of cerebral injury in the antiphospholipid antibody syndrome of systemic lupus erythematosus. Stroke 1998;29:2254-60.
25. Sibbitt WL Jr, Haseler LJ, Griffey RR, Friedman SD, Brooks WM. Neurometabolism of active neuropsychiatric lupus determined with proton MR spectroscopy. AJNR Am J Neuroradiol 1997;18:1271-7.
26. DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001;7:1189-93.
27. Ozawa S, Kamiya U, Tsuzuki K. Glutamate receptors in the mammalian central nervous system. Prog Neurobiol 1998;54:581-618.
28. Collingridge GL, Isaac JT, Wang YT. Receptor trafficking and synaptic plasticity. Nat Rev Neurosci 2004;5:952-62.
29. Malenka RC, Nicoll RA. Long-term potentiation-a decade of progress? Science 1959;285:1870-4.
30. Kowal C, DeGiorgio LA, Nakaoka T, Hetherington H, Huerta PT, Diamond B, et al. Cognition and immunity: antibody impairs memory. Immunity 2004;21:179-88.
31. Huerta PT, Kowal C, De Georgio LA, Volpe BT, Diamond B. Immunity and behavior: antibodies alter emotion. Proc Natl Acad Sci U S A 2006;103:678-83.
32. Skolnick P. Modulation of glutamate receptors: strategies for the development of novel antidepressants. Amino Acids 2002;23:153-9.
33. Law AJ, Deakin JF. Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses. Neuroreport 2001;12:2971-4.
34. Nowak G, Ordway GA, Paul IA. Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims. Brain Res 1995;675:157-64.
35. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 1982;25:1271-7.
36. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
37. Beck AT, Steer RA, Brown GK. Beck Depression Inventory-Second Edition manual. San Antonio: The Psychological Corporation; 1996.
38. American Psychiatric Association. Diagnostic and statistical manual of mental disorders DSM-IV. 4th ed. Washington, DC: American Psychiatric Association; 1994.
39. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
40. Petri M, Buyon J, Kim M. Classification and definition of major flares in SLE clinical trials. Lupus 1999;8:685-91.
41. Delis DC, Kramer JH, Kaplan E, Ober BA. The California Verbal Learning Test: adult version. San Antonio: The Psychological Corporation; 1987.
42. Meyers JE. Rey Complex Figure, Test and Recognition Trial. Lutz (FL): Psychological Assessment Resources; 1995.
43. Golden CA. Stroop Color and Word Test Manual. Chicago: Stoelting; 1978.
44. Wechsler D. Wechsler Adult Intelligence Scale. 3rd ed. San Antonio (TX): The Psycological Corporation; 1997.
45. Spreen O, Strauss E. A compendium of neuropsychological tests: administration, norms, and commentary. 2nd ed. New York: Oxford University Press; 1998.
46. Johnstone B, Hexum CL, Ashkanazi G. Extent of cognitive decline in traumatic brain injury based on estimates of premorbid intelligence. Brain Inj 1995;9:377-84.
47. Duyn JH, Gillen J, Sobering G, van Zijl PC, Moonen CT. Multisection proton MR spectroscopic imaging of the brain. Radiology 1993;188:277-82.
48. Van der Veen JW, Weinberger DR, Tedeschi G, Frank JA, Duyn JH. Proton MR spectroscopic imaging without water suppression. Radiology 2000;217:296-300.
49. Chinn RJ, Wilkinson ID, Hall-Craggs MA, Paley MN, Shortall E, Carter S, et al. Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:36-46.
50. Ainiala H, Hietaharju A, Dastidar P, Loukkola J, Lehtimaki T, Peltola J, et al. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance abnormalities. Arthritis Rheum 2004;50:858-65.
51. Omdal R, Brokstad K, Waterloo K, Koldingsnes W, Jonsson R, Mellgren SI. Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors. Eur J Neurol 2005;12:392-8.
52. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000;47:351-4.
53. Kudoh A, Takahira Y, Katagai H, Takazawa T. Small-dose ketamine improves the postoperative state of depressed patients. Anesth Analg 2002;95:114-8.
54. Ambrozi L, Danielczyk W. Treatment of impaired cerebral function in psychogeriatric patients with memantine: results of a phase II double-blind study. Pharmacopsychiatry 1988;21:144-6.
55. Kareken DA, Gur RC, Saykin AJ. Reading on the Wide Range Achievement Test-Revised and parental education as predictors of IQ: comparison with the Barona formula. Arch Clin Neuropsychol 1995;10:147-57.
56. Griffin SL, Mindt MR, Rankin EJ, Ritchie AJ, Scott JG. Estimating premorbid intelligence: comparison of traditional and contemporary methods across the intelligence continuum. Arch Clin Neuropsychol 2002;17:497-507.